Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction

Summary

The local literature lacks comprehensive information regarding the actual incidence of intrauterine growth restriction (IUGR) and oligohydramnios and currently available therapeutic options. Therefore, the current study was planned with the objective to evaluate the impact of enoxaparin therapy compared with standard management on neonatal outcomes in pregnancies complicated by intrauterine growth restriction (IUGR) with oligohydramnios.

Timeline

Start

2026-04-01

Primary completion

2026-09-30

Completion

2026-09-30

Drugs

Indications